T C Rodwell
Overview
Explore the profile of T C Rodwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burger Z, Aung H, Seifert M, Mar T, Harris V, Colman R, et al.
Int J Tuberc Lung Dis
. 2022 Aug;
26(9):875-879.
PMID: 35996278
Xpert MTB/RIF, a rapid, molecular TB diagnostic assay, can detect and rifampin resistance directly from clinical sputum samples in <2 h with high sensitivity and specificity. The added diagnostic value...
2.
Ramirez-Busby S, Rodwell T, Fink L, Catanzaro D, Jackson R, Pettigrove M, et al.
Sci Rep
. 2017 Jun;
7(1):3790.
PMID: 28630430
Pyrazinamide (PZA) is an important first-line drug in all existing and new tuberculosis (TB) treatment regimens. PZA-resistance in M. tuberculosis is increasing, especially among M/XDR cases. Noted issues with PZA...
3.
Conners E, Garfein R, Rodwell T, Udwadia Z, Catanzaro D
Int J Tuberc Lung Dis
. 2016 Dec;
20(12):1633-1638.
PMID: 27931339
Setting: Tuberculosis (TB) hospital in Mumbai, India. Objective: To describe the mobility patterns of persons with suspected drug-resistant tuberculosis (DR-TB) and to assess whether there were significant differences in demographic...
4.
Valafar F, Ramirez-Busby S, Torres J, Paul L, Rodwell T, Victor T, et al.
Int J Mycobacteriol
. 2016 Oct;
4(Suppl 1):51-52.
PMID: 27695670
Background: By using whole genome sequencing (WGS), researchers are beginning to understand the genetic diversity of (MTB) and its consequences for the diagnosis of multidrug-resistant tuberculosis (MDR-TB) on a genomic...
5.
Georghiou S, Seifert M, Catanzaro D, Garfein R, Valafar F, Crudu V, et al.
Antimicrob Agents Chemother
. 2016 Apr;
60(7):3994-4004.
PMID: 27090176
Molecular diagnostic assays, with their ability to rapidly detect resistance-associated mutations in bacterial genes, are promising technologies to control the spread of drug-resistant tuberculosis (DR-TB). Sequencing assays provide detailed information...
6.
Seifert M, Ajbani K, Georghiou S, Catanzaro D, Rodrigues C, Crudu V, et al.
Int J Tuberc Lung Dis
. 2016 Apr;
20(5):631-7.
PMID: 27084817
Objective: To evaluate the performance of a recently updated rapid molecular diagnostic test, GenoType® MTBDRplus version 2, designed to detect drug resistance in both acid-fast bacilli (AFB) smear-negative and -positive...
7.
Georghiou S, Ajbani K, Rodrigues C, Rodwell T
Int J Tuberc Lung Dis
. 2016 Jan;
20(2):160-5.
PMID: 26792466
Setting: Pyrosequencing diagnostic assays have shown great utility in identifying and characterizing pulmonary drug-resistant tuberculosis (TB) infections. However, the method has yet to be evaluated for the diagnosis of drug-resistant...
8.
Nikam C, Patel R, Sadani M, Ajbani K, Kazi M, Soman R, et al.
Int J Tuberc Lung Dis
. 2016 Jan;
20(2):154-9.
PMID: 26792465
Background: Although line-probe assays (LPAs) are promising, little research has been conducted to elucidate the true nature of indeterminate LPA results or assess the ability of these assays to perform...
9.
Kambli P, Ajbani K, Nikam C, Khillari A, Shetty A, Udwadia Z, et al.
Int J Tuberc Lung Dis
. 2015 Oct;
19(10):1227-9.
PMID: 26459538
The purpose of the present study was to correlate gyrA mutations found in Mycobacterium tuberculosis isolates using the GenoType(®) MTBDRsl assay with minimum inhibitory concentrations of the fluoroquinolone levofloxacin (LVX)....
10.
ElMaraachli W, Slater M, Berrada Z, Lin S, Catanzaro A, Desmond E, et al.
Int J Tuberc Lung Dis
. 2015 Oct;
19(10):1222-6.
PMID: 26459537
Setting: Rifampin (RMP) resistant Mycobacterium tuberculosis is usually assumed to be resistant to all rifamycins. Increasing evidence indicates, however, that some rpoB mutations, detectable by rapid molecular diagnostics, confer resistance...